Skip to content
Search
SEARCH FOR AN ARTICLE
Home
new biotech stocks
new biotech stocks
![Agios Presents Updated PYRUKYND® (mitapivat) Data Highlighting Long-term Safety Profile and Durable Improvement in Hemoglobin and Markers of Hemolysis and Ineffective Erythropoiesis in Non-transfusion-dependent ?- and ?-Thalassemia at 64th ASH Annual Meeting and Exposition]()
December 10, 2022
![Fate Therapeutics Highlights iPSC-derived, Off-the-shelf CAR NK Cell Programs for Multiple Myeloma at 2022 ASH Annual Meeting]()
December 10, 2022
![argenx to Present Pivotal ADVANCE Trial Data During ASH Plenary Session Highlighting VYVGART® (efgartigimod alfa-fcab) as Potential New Treatment Modality for Immune Thrombocytopenia]()
December 10, 2022
![Fate Therapeutics Announces Clinical Safety and Activity Data of First-ever iPSC-derived CAR T-cell Therapy at 2022 ASH Annual Meeting]()
December 10, 2022
![Adaptive Biotechnologies Highlights New Data Showcasing the Clinical Utility of clonoSEQ® MRD Testing in Patients with Blood Cancers at the 64th ASH Annual Meeting]()
December 10, 2022
![Exelixis (EXEL) Reports Data from CONTACT-01, QUARTZ-101 Study]()
December 9, 2022
![Allakos Inc. (ALLK) Moves to Buy: Rationale Behind the Upgrade]()
December 9, 2022
![BIIB vs. TECH: Which Stock Is the Better Value Option?]()
December 9, 2022
![Clovis (CLVS) Down 18.1% Since Last Earnings Report: Can It Rebound?]()
December 9, 2022
![Alnylam (ALNY) Seeks to Expand Onpattro Label in Cardiomyopathy]()
December 9, 2022
